社区PrEP研究:利用社区平台改善南非少女和年轻女性HIV暴露前预防可及性与依从性的随机对照试验方案
该方案针对南非东开普省16-25岁少女和年轻女性,采用混合方法研究。第一部分横断面评估利用社区HIV咨询检测平台转介至非诊所当日PrEP启动服务的可接受性与可行性;第二部分将480名经社区平台启动PrEP者按1:1:1随机分组,评估依从支持干预对预防有效性使用的影响,通过替诺福韦二磷酸血药浓度随访24个月。
要点
- 社区HIV咨询检测平台可转介高风险AGYW至当日非诊所PrEP启动服务。
- 480名AGYW随机接受三种依从支持干预,以血药浓度评估24个月依从性。
- 同时评估服务成本与可扩展性,并开展定性研究探索体验。
核心结论
- 这是首个评估利用社区HIV咨询检测平台转介高风险AGYW至社区当日PrEP启动服务可接受性与可行性的研究。
- 研究将提供定量与定性结果,为促进AGYW预防有效性使用PrEP的依从支持活动与服务提供依据。
研究设计与样本
- 混合方法研究,在南非东开普省16-25岁AGYW中开展。
- 第一部分为横断面研究,评估利用社区HIV咨询检测平台转介至非诊所当日PrEP启动服务的可接受性与可行性。
- 第二部分为三臂1:1:1随机对照试验,纳入480名经社区平台启动PrEP的AGYW,评估依从支持干预效果。
- 通过替诺福韦二磷酸血药浓度水平随访24个月测量依从性,并开展定性调查与成本可扩展性评估。
临床怎么用
- 利用社区HIV咨询检测平台识别并转介高风险AGYW至社区当日PrEP启动服务。
- 通过依从支持干预促进AGYW预防有效性使用PrEP。
- 结合实施科学、行为科学与卫生经济学研究原则,为改善PrEP可及性与预防有效性使用提供策略。
局限性
- 试验为回顾性注册(2019年6月6日)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: HIV incidence among South African adolescent girls and young women (AGYW) remains high, but could be reduced by highly effective pre-exposure prophylaxis (PrEP). Unfortunately, AGYW report significant barriers to clinic-based sexual and reproductive health services. Even when AGYW access PrEP as an HIV prevention method, poor prevention-effective use was a serious barrier to achieving its optimal HIV prevention benefits. Determining the acceptability and feasibility of community-based platforms to increase AGYW's access to PrEP, and evaluating behavioural interventions to improve prevention-effective use of PrEP are needed. METHODS: We propose a mixed-methods study among AGYW aged 16-25 years in Eastern Cape Province, South Africa. In the first component, a cross-sectional study will assess the acceptability and feasibility of leveraging community-based HIV counselling and testing (CBCT) platforms to refer HIV-negative, at-risk AGYW to non-clinic-based, same-day PrEP initiation services. In the second component, we will enrol 480 AGYW initiating PrEP via our CBCT platforms into a three-armed (1:1:1) randomized control trial (RCT) that will evaluate the effectiveness of adherence support interventions to improve the prevention-effective use of PrEP. Adherence will be measured over 24 months via tenofovir-diphosphate blood concentration levels. Qualitative investigations will explore participant, staff, and community experiences associated with community-based PrEP services, adherence support activities, study implementation, and community awareness. Costs and scalability of service platforms and interventions will be evaluated. DISCUSSION: This will be the first study to assess the acceptability and feasibility of leveraging CBCT platforms to identify and refer at-risk AGYW to community-based, same-day PrEP initiation services. It will also provide quantitative and qualitative results to inform adherence support activities and services that promote the prevention-effective use of PrEP among AGYW. By applying principles of implementation science, behavioural science, and health economics research, we aim to inform strategies to improve access to and prevention-effective use of PrEP by AGYW. TRIAL REGISTRATION: ClinicalTrials.gov NCT03977181 . Registered on 6 June 2019-retrospectively registered.
引用
- Medina-Marino A, Bezuidenhout D, Hosek S, et al. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol. Trials. 2021. PMID: 34311754. doi:10.1186/s13063-021-05402-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。